打铁不如李铁
04-15
$宝济药业-B(02659)$
公司的长期投资价值在于其合成生物学技术平台能否持续产出具有竞争力的产品,实现平台型生物制药公司的转型
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":553825271678504,"tweetId":"553825271678504","gmtCreate":1776245822500,"gmtModify":1776245824450,"author":{"id":4193625296607780,"idStr":"4193625296607780","authorId":4193625296607780,"authorIdStr":"4193625296607780","name":"打铁不如李铁","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":5,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02659\">$宝济药业-B(02659)$ </a> 公司的长期投资价值在于其合成生物学技术平台能否持续产出具有竞争力的产品,实现平台型生物制药公司的转型</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02659\">$宝济药业-B(02659)$ </a> 公司的长期投资价值在于其合成生物学技术平台能否持续产出具有竞争力的产品,实现平台型生物制药公司的转型</p></body></html>","text":"$宝济药业-B(02659)$ 公司的长期投资价值在于其合成生物学技术平台能否持续产出具有竞争力的产品,实现平台型生物制药公司的转型","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/553825271678504","repostId":0,"isVote":1,"tweetType":1,"viewCount":346,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02659"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":118,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/553825271678504"}
精彩评论